These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3158885)

  • 1. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
    Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
    Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
    Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-diphosphonate whole-body retention measurements using a conic-beam collimator and a scintillation detector.
    Vattimo A
    J Nucl Med Allied Sci; 1987; 31(3):291-4. PubMed ID: 3121810
    [No Abstract]   [Full Text] [Related]  

  • 4. Nuclear medicine studies in evaluation of skeletal lesions in children with histiocytosis X.
    Siddiqui AR; Tashjian JH; Lazarus K; Wellman HN; Baehner RL
    Radiology; 1981 Sep; 140(3):787-9. PubMed ID: 6456475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
    Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
    Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [24-hour whole-body retention of 99mTc-methylene diphosphonate as an indicator of metabolic activity in osseous tissue in osteopathies].
    Kapitola J; Jahoda I; Kobos L; Vilimovská D
    Cas Lek Cesk; 1986 Jun; 125(26):815-6. PubMed ID: 3087622
    [No Abstract]   [Full Text] [Related]  

  • 8. [Skeletal scintigraphic findings in spinal diseases].
    Moser E
    Radiologe; 1989 Apr; 29(4):164-9. PubMed ID: 2498988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
    Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
    Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM; Moore AE; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
    Molloi S; Mazess R; Bendsen H; Wilson M
    Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 13. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

  • 16. Gamma camera energy windows for Tc-99m bone scintigraphy: effect of asymmetry on contrast resolution. Work in progress.
    Collier BD; Palmer DW; Knobel J; Isitman AT; Hellman RS; Zielonka JS
    Radiology; 1984 May; 151(2):495-7. PubMed ID: 6231657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do we want from a bone-scanning agent?
    Fogelman I; Bessent RG
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract]   [Full Text] [Related]  

  • 19. Technetium-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (99mTc-DHPE). A promising new skeletal imaging agent.
    Archimandritis SC; Tsolis AK
    Eur J Nucl Med; 1987; 13(3):134-8. PubMed ID: 3622557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vistas on bone scintigraphy.
    Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.